Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

This study has been completed.

Study NCT00051987 Information provided by Millennium Pharmaceuticals, Inc.

First Received: January 21, 2003 Last Updated: February 7, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2004 (Final data collection date for primary outcome measure)